EichorEICHOR
Study identifier: NCT07623200 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Recruiting

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

Condition: Essential Thrombocythemia  ·  Sponsor: Incyte Corporation

PhasePhase 3
Planned participants426
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is being conducted to evaluate INCA033989 versus best available therapy in participants with essential thrombocythemia and a CALR mutation previously treated with cytoreductive therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Incyte Corporation Call Center (US)  ·  1.855.463.3463  ·  medinfo@incyte.com

Incyte Corporation Call Center (ex-US)  ·  +800 00027423  ·  eumedinfo@incyte.com

Always discuss trial participation with your own doctor first.

Locations (180)

Banner Md Anderson Cancer CenterGilbert, Arizona, United StatesNot Yet Recruiting
The University of Arizona Cancer CenterTucson, Arizona, United StatesNot Yet Recruiting
City of Hope Medical CenterDuarte, California, United StatesNot Yet Recruiting
Marin Cancer CareGreenbrae, California, United StatesRecruiting
University of California, Los Angeles Medical CenterLos Angeles, California, United StatesNot Yet Recruiting
Stanford Cancer CenterPalo Alto, California, United StatesNot Yet Recruiting
UCSFSan Francisco, California, United StatesWithdrawn
Rocky Mountain Cancer Centers-Lone TreeLone Tree, Colorado, United StatesNot Yet Recruiting
Medstar Georgetown Medical Center, IncWashington D.C., District of Columbia, United StatesNot Yet Recruiting
Florida Cancer Specialists & Research InstituteFort Myers, Florida, United StatesNot Yet Recruiting
University of Miami Sylvester Comprehensive Cancer CenterMiami, Florida, United StatesNot Yet Recruiting
Cleveland ClinicWeston, Florida, United StatesNot Yet Recruiting

+ 168 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →